- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02369822
Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy
February 23, 2015 updated by: Shaymaa Maher Deifalla, Ain Shams University
There are no solid treatment guidelines for idiopathic intractable epilepsy in children.
The investigators propose that vitamin C being an antioxidant will improve seizure frequency and EEG in children with idiopathic intractable epilepsy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Is vitamin C; being an antioxidant based on the hypothesis of oxidative stress as a provocation factor for idiopathic epilepsy low in those with idiopathic epilepsy, and is it lower in those with refractory than those with newly diagnosed?
Will vitamin C supplementation for 1 month be efficient to raise the vitamin C level and will it improve seizures and EEG findings in those with idiopathic epilepsy?
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nasr City
-
Cairo, Nasr City, Egypt
- Shaymaa Maher Deifalla
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal neuroimaging
Exclusion Criteria:
- Developmental delay.
- Suspected metabolic problems.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vitamin C supplemented
patients with refractory idiopathic epilepsy will receive vitamin C supplement according to age for 1 month
|
those who are 2-3 years will receive 400 mg/day, 4-8 years will receive 500 mg/day, those who are 9-13 years will receive 1000 mg/day, and from 14-16 years will receive 1500 mg/day
|
|
No Intervention: None supplemented
followed up for 1 month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Seizure severity and frequency, EEG findings
Time Frame: up to 30 days
|
Seizure severity based on the Chalfont seizre severity scale and daily seizure frequency will be measured before and 30 days after vitamin C supplementation in children with intractable idiopathic epilepsy
|
up to 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
vitamin C level in children with epilepsy
Time Frame: 6 months
|
children with epilepsy will be recruited over a period of 6 months and we will measure vitamin C level in their blood
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Iman A Elagouza, A Professor, Faculty of Medicine, Ain Shams University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Anticipated)
September 1, 2015
Study Completion (Anticipated)
March 1, 2016
Study Registration Dates
First Submitted
February 11, 2015
First Submitted That Met QC Criteria
February 23, 2015
First Posted (Estimate)
February 24, 2015
Study Record Updates
Last Update Posted (Estimate)
February 24, 2015
Last Update Submitted That Met QC Criteria
February 23, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vitamin C, Children, Epilepsy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Epilepsy
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Generalized EpilepsyFrance
-
University Hospital, LilleTerminatedIdiopathic Generalized EpilepsyFrance
-
NYU Langone HealthActive, not recruiting
-
Mazandaran University of Medical SciencesCompletedTreatment of Idiopathic Generalized EpilepsyIran, Islamic Republic of
-
Shen Chun-HongRecruiting
-
SK Life Science, Inc.Enrolling by invitationPrimary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized EpilepsyUnited States, Bulgaria, Czechia, Hungary, Slovakia, Ukraine, Poland
-
University of AlexandriaCompletedEpilepsy Generalized Idiopathic Not Intractable
-
Dokuz Eylul UniversityCompleted
-
NeuroPaceActive, not recruitingEpilepsy | Idiopathic Generalized Epilepsy | Generalized Tonic Clonic SeizureUnited States
-
Eisai LimitedCompletedIdiopathic Generalized Epilepsy | Partial Onset Seizures | Generalised Tonic-Clonic SeizuresFrance, Spain, Italy, Denmark, Germany, Portugal, Russian Federation
Clinical Trials on Vitamin C
-
Qualia Life SciencesCompleted
-
Shiraz University of Medical SciencesCompletedRestless Legs Syndrome | Kidney Failure, ChronicIran, Islamic Republic of
-
Ohio State UniversityRecruitingAdequate Vitamin C Status | Inadequate Vitamin C StatusUnited States
-
Al-Azhar UniversityRecruitingGingival Hyperpigmentation | Gingival Melanin PigmentationEgypt
-
Fan ZengRecruiting
-
TCI Co., Ltd.CompletedVitamin C DeficiencyTaiwan
-
Ain Shams UniversityCompletedEnd-Stage Renal Disease | Vitamin C | Erythropoietin | Oral Administration | Regular HemodialysisEgypt
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v7United States
-
Cairo UniversityNot yet recruiting